Also trades as: CERO (OTC) · $vol 0M
CEROW OTC
CERo Therapeutics Holdings, Inc.
1W: -45.1%
1M: +94.5%
3M: -71.5%
YTD: -57.2%
1Y: -88.0%
$0.00
+0.00 (+18.89%)
Weekly Expected Move ±256.2%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$1M
-4.1% ▼
Operating Income
-$15M
-421.7% ▼
Net Income
-$8M
-304789.6% ▼
EPS (Diluted)
$-6.87
+99.7% ▲
EBITDA
-$7M
-169.4% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $1M | $1M |
| Gross Profit | $0 | $0 | -$1M | -$1M |
| Gross Margin | — | — | — | — |
| R&D Expenses | $9M | $10M | $0 | $6M |
| SG&A Expenses | $2M | $3M | $3M | $9M |
| Operating Expenses | $431K | $3M | $3M | $15M |
| Operating Income | -$332K | -$3M | -$3M | -$15M |
| Operating Margin | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $0 |
| Income Before Tax | -$332K | -$69K | -$2M | -$8M |
| Tax Expense | -$17K | $599K | $95K | $0 |
| Net Income | -$316K | -$668K | -$3K | -$8M |
| Net Margin | — | — | — | — |
| EPS (Diluted) | $-2.75 | $-19.73 | $-2497.20 | $-6.87 |
| EBITDA | $403K | -$69K | -$2M | -$7M |
| Shares Outstanding | 7353 | 7353 | 7353 | 120794 |